The National Cancer Institute is offering grants to accelerate the development of cancer therapeutics, imaging technologies, interventional devices, diagnostics, and prognostics towards commercialization. Small businesses previously funded under SBIR or STTR Phase II awards can apply for additional funding. The projects should focus on cancer-related areas such as therapeutics, imaging technologies, diagnostics, and prognostics. The grant aims to transition projects to the commercialization stage by promoting partnerships with investors and strategic partners. Applicants must submit a Commercialization Plan detailing third-party investor funding. Clinical trial proposals are accepted but not required. Closing date for applications is July 13, 2016.
Opportunity ID: 281606
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-16-008 |
| Funding Opportunity Title: | SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 18, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 13, 2016 |
| Current Closing Date for Applications: | Jul 13, 2016 |
| Archive Date: | Aug 13, 2016 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and/or in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-008.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00221648 | Jun 13, 2016 | Jul 13, 2016 | View | |
| FORMS-C | FORMS-C | PKG00221036 | Mar 17, 2016 | Mar 18, 2016 | View |
Package 1
Mandatory forms
281606 RR_SF424_2_0-2.0.pdf
281606 PHS398_CoverPageSupplement_3_0-3.0.pdf
281606 RR_OtherProjectInfo_1_3-1.3.pdf
281606 PerformanceSite_2_0-2.0.pdf
281606 RR_KeyPersonExpanded_2_0-2.0.pdf
281606 RR_Budget_1_3-1.3.pdf
281606 PHS398_ResearchPlan_3_0-3.0.pdf
281606 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
281606 RR_SubawardBudget30_1_3-1.3.pdf
281606 PHS_Inclusion_Enrollment_Report-1.0.pdf
281606 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
281606 RR_SF424_2_0-2.0.pdf
281606 PHS398_ResearchPlan_2_0-2.0.pdf
281606 SBIR_STTR_Information_1_1-1.1.pdf
281606 RR_KeyPersonExpanded_2_0-2.0.pdf
281606 RR_OtherProjectInfo_1_3-1.3.pdf
281606 RR_Budget_1_3-1.3.pdf
281606 PerformanceSite_2_0-2.0.pdf
281606 PHS398_CoverPageSupplement_2_0-2.0.pdf
Optional forms
281606 RR_SubawardBudget30_1_3-1.3.pdf
281606 PlannedReport-1.0.pdf
281606 PHS398_CumulativeInclusionReport-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
